期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血管紧张素转换酶抑制剂的临床应用进展 被引量：2

原文传递
导出
摘要 血管紧张素转换酶抑制剂（Angiotesion converting enzyme inhibitors,ACEI）是20世纪80年代发展起来的一类应用最广的抗高血压药（包括药物引起的高血压）和抗充血性心力衰竭药,也应用于预防左心室肥大、
作者 李文举 李敏 张伟
机构地区 广东佛山市南海区九江镇医院 兰州大学第二医院药剂科 重庆医科大学附属第一医院外科
出处 《中国药房》 CAS CSCD 北大核心 2010年第20期1918-1920,共3页 China Pharmacy
关键词 血管紧张素转换酶抑制剂 临床应用 充血性心力衰竭 抗高血压药 左心室肥大
分类号 R972.4 [医药卫生—药品]
  • 相关文献

参考文献20

  • 1Maitland ML, Kasza KE, Karrison T, et al. Ambulatory monitoring detects sorafenib induced blood pressure elevations on the first day of treatment[J]. Clin Cancer Res, 2009, 15(19): 6 250.
  • 2Da Cunha V, Tham DM, Martin McNulty B, et al. Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation[J]. Atherosclerosis, 2005, 178( 1 ) : 9.
  • 3Manning J, Vehaskari VM.Postnatal modulation of prenatally programmed hypertension by dietary Na and ACE inhibition[J]. Am J Physiol Regul Integr Comp Physiol, 2005, 288(1): RS0.
  • 4Schofield RS, Kline SE, Schmalfuss CM, et al. Early outoutcomes of a care coordination-enhanced telehome care program for elderly veterans with chronic heart failure[J]. TelemedJEHealth, 2005, 11(1): 20.
  • 5Ishani A, Weinhandl E, Zhao Z, et al. Angiotensin-convetting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction[J]. J Am Coil Cardiol, 2005, 45(3) : 391.
  • 6Shao Q, Ren B, Saini HK, et al. Sarcoplasmic reticulum Ca^2+ transport and gene expression in congestive heart failure are modified by imidapril treatment[J]. Am J Physiol Heart Circ Physiol, 2005,288(4) : 1 674.
  • 7Srinivasan J, Jayadev S, Kumaran D, et al. Effect of losartan and enalapril on cognitive deficit caused by Goldblatt induced hypertension[J], lndian J Exp Biol, 2005, 43 (3):241.
  • 8Barnett AH. Preventing renal complications in diabetic patients: the diabetics exposed to telmisartan and enalaprlL (DETAIL) study[J]. Acta Diabetol, 2005,42 (4) : 42.
  • 9Winer N, Folker A, Murphy JA, et al. Effect of fixeddose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes[J]. Prey Cardiol, 2005, 8(2 ) : 87.
  • 10Wilkinson-Berka JL, Gibbs N J, Cooper ME, et al. Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2) 27 rat[J]. Nephrol Dial Transplat, 2001,16(7):1 343.

二级参考文献48

  • 1刘力生,龚兰生,王文,降压治疗预防卒中再发研究协作组.降压治疗对中国脑血管病患者脑卒中再发预防的多中心随机双盲对照临床研究[J].中华心血管病杂志,2005,33(7):613-617. 被引量：48
  • 2Maitland ML,Kasza KE, Karrison T, et al. Ambulatory monitoring detects sorafenib induced blood pressure elevations on the first day of treatment [ J]. Clin Cancer Res,2009,15(19) :6 250.
  • 3Da Cunha V, Tham DM, Martin McNulty B, et al. Enalapril attenuates angiotensin Ⅱ - induced atherosclerosis and vascular inflammation [ J]. Atherosclerosis, 2005,178 ( 1 ) :9.
  • 4Manning J, Vehaskari VM. Postnatal modulation of prenatally programmed hypertension by dietary Na and ACE inhibition [ J ]. Am J Physiol Regul Integr Comp Physiol, 2005,288 ( 1 ) : R80.
  • 5Schofield RS, Kline SE, Schmalfuss CM, et al. Early outcomes of a care coordination - enhanced telehome care program for elderly veterans with chronic heart failure [ J ]. Telemed J E Health, 2005,11 ( 1 ) : 20.
  • 6Ishani A, Weinhandl E, Zhao Z, et al. Angiotensin - converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction[ J].J Am Coll Cardiol,2005 , 4 5 ( 3 ) :391.
  • 7Shao Q, Ren B, Saini HK, et al. Sarcoplasmic reticulum Ca^2+ transport and gene expression in congestive heart failure are modified by imidapril treatment [ J ]. Am J Physiol Heart Circ Physiol,2005,288 (4) : H 1 674.
  • 8Srinivasan J, Jayadev S, Kumaran D, et al. Effect of losartan and enalapril on cognitive deficit caused by Goldblatt induced hypertension [ J ]. Indian J Exp Biol, 2005,43 (3) :241.
  • 9Barnett AH. Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study [ J ]. Acta Diabetol, 2005,42 ( Suppl 1 ) : S42.
  • 10Winer N, Folker dose ACE - A, Murphy JA, et al inhibitor/calcium Effect of fixed - channel blocker combination therapy vs. ACE - inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes [ J ]. Prey Cardiol,2005,8 ( 2 ) : 87.

共引文献59

同被引文献11

引证文献2

二级引证文献6

中国药房
2010年 第20期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部